CRISPR Therapeutics
CRSP
CRSP
379 hedge funds and large institutions have $2.54B invested in CRISPR Therapeutics in 2023 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 102 increasing their positions, 120 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
379
Holders Change
-16
Holders Change %
-4.05%
% of All Funds
6.07%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
48
Increased
102
Reduced
120
Closed
57
Calls
$79.7M
Puts
$71.8M
Net Calls
+$7.92M
Net Calls Change
-$15.3M
Top Buyers
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$22.4M |
| 2 |
2
Goldman Sachs
New York
|
$10.7M |
| 3 |
PI
3
PEAK6 Investments
Chicago,
Illinois
|
$2.26M |
| 4 |
AC
4
Armistice Capital
New York
|
$37.3M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$11.1M |
